NasdaqCM - Nasdaq Real Time Price
USD
Hyperion DeFi, Inc. (HYPD)
3.1109
+0.1409
(+4.73%)
As of 9:49:46 AM EST. Market Open.
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Hyunsu Jung
|
CEO, Chief Investment Officer & Director | 136.09k | -- | 1996 |
|
Mr. David Knox C.F.A.
|
Chief Financial Officer and Treasurer | 179.82k | -- | 1990 |
|
Mr. Robert Rubenstein
|
General Counsel & Secretary | -- | -- | 1967 |
|
Jason Assad
|
Investor Contact | -- | -- | -- |
|
Alexander Lobo
|
Investor Contact | -- | -- | -- |
Hyperion DeFi, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 9
Description
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
Corporate Governance
Hyperion DeFi, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 12, 2026 at 1:30 PM UTC
Hyperion DeFi, Inc. Earnings Date
